Literature DB >> 16602250

The effect of hyperbaric oxygen on intraocular pressure.

D Ersanli1, T Akin, S Yildiz, A Akin, A H Bilge, G Uzun.   

Abstract

The effects of hyperoxia on intraocular pressure (IOP) have been studied in experiments on human beings and animals. The changes occurring in IOP in patients during routine HBO2 therapy are unknown. In this study we investigated IOP changes arising during the HBO2 therapy at 2.5 ATA. Fifty-six patients receiving HBO2 therapy for various reasons were included in the study. Bilateral IOPs of patients measured with the Tono-pen XL (Medtronic, Solan, USA) tonometer before, during and after HBO2 therapy. Average IOPs were 14.85 +/- 3.17 mmHg (range, 10-24), 13.00 +/- 2.97 mmHg (range, 9-21) and 14.74 +/- 3.12 mmHg (range, 10-22), respectively. IOP was reduced significantly during HBO2 therapy and returned its pre- HBO2 levels after therapy. Our data indicated a statistically significant decrease in IOPs during therapy at 2.5 ATA. This decrease was of minor physiological significance in these patients whose baseline IOP values were within the normal range.

Entities:  

Mesh:

Year:  2006        PMID: 16602250

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  3 in total

1.  Efficacy of Hyperbaric Oxygen Therapy on Central Corneal Thickness, Intraocular Pressure, and Nerve Fiber Layer in Patients with Type 2 Diabetes: A Prospective Cohort Study.

Authors:  Havva Kaldırım; Kürsat Atalay; Banu Ceylan; Serpil Yazgan
Journal:  Korean J Ophthalmol       Date:  2020-12-11

2.  Effects of chronic mild hyperoxia on retinal and choroidal blood flow and retinal function in the DBA/2J mouse model of glaucoma.

Authors:  Eric R Muir; Saurav B Chandra; Divya Narayanan; Vincent Zhang; Ike Zhang; Zhao Jiang; Jeffrey W Kiel; Timothy Q Duong
Journal:  PLoS One       Date:  2022-03-25       Impact factor: 3.240

Review 3.  Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy.

Authors:  Charles McMonnies
Journal:  J Optom       Date:  2017-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.